Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

Merck gets USFDA nod for WINREVAIR (sotatercept-csrk) for adults with pulmonary arterial hypertension

Ruchika Sharma27 March 2024 11:51 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...

Indoco Remedies arm begins commercial production of Pharmaceutical Intermediates

Ruchika Sharma26 March 2024 3:30 PM IST

Mumbai: Warren Remedies Private Limited, a Wholly Owned Subsidiary of Indoco Remedies Limited has commenced its commercial production from its...

AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: Report

AstraZeneca Pharma India names Vinay Sharma as Business Unit Head

Ruchika Sharma26 March 2024 2:12 PM IST

Bangalore: AstraZeneca Pharma India Limited has announced the appointment of Vinay Sharma as Business Unit Head - Rare Disease unit with effect...

AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium Cyclosilicate

AstraZeneca Ultomiris gets USFDA approval for adults with neuromyelitis optica spectrum disorder

Ruchika Sharma26 March 2024 12:52 PM IST

Ultomiris, a long-acting C5 complement inhibitor, provides immediate, complete and sustained complement inhibition.

One Death a Day: 1,705 Lives Lost in Indias Clinical Trials Since 2021, RTI Reveals

Bharat Biotech begins clinical trial of Tuberculosis vaccine MTBVAC in India

Ruchika Sharma26 March 2024 12:34 PM IST

Hyderabad: Clinical trials of MTBVAC, the Spanish tuberculosis vaccine, the first live attenuated vaccine of Mycobacterium tuberculosis isolated...

Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license

Bayer, Thermo Fisher Scientific join hands to increase patient access to precision cancer medicines

Ruchika Sharma25 March 2024 12:30 PM IST

Berlin: Bayer AG and Thermo Fisher Scientific Inc. have announced a collaboration to develop next-generation sequencing (NGS)-based companion...

Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million

Lonza to buy large-scale biologics Vacaville site from Roche for USD 1.2 billion

Ruchika Sharma25 March 2024 10:00 AM IST

Basel: Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced it has signed an agreement...

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus Phase III CT Waiver Request for Voclosporin

Zydus Lifesciences receives tentative approval from USFDA for Letermovir Tablets

Ruchika Sharma24 March 2024 2:30 PM IST

Letermovir tablets are used to prevent disease caused by a virus called cytomegalovirus in people who have received a bone marrow transplant or kidney...

Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal

Novartis Fabhalta gets positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria

Ruchika Sharma24 March 2024 2:30 PM IST

Basel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...

Advent to Sell Zentiva to Private Equity GTCR in USD 4.8 Billion Deal, Closing Expected in 2026

Gilead Sciences completes acquisition of CymaBay Therapeutics for USD 4.3 billion

Ruchika Sharma24 March 2024 11:00 AM IST

As a result of the completion of the merger, CymaBay has become a wholly owned subsidiary of Gilead.

Bill & Melinda Gates Medical Research Institute begins Phase 3 clinical trial of Tuberculosis vaccine

Ruchika Sharma24 March 2024 10:00 AM IST

Cambridge: The Bill & Melinda Gates Medical Research Institute (Gates MRI) has announced that a Phase 3 clinical trial to assess the efficacy of...

Mounjaro, Wegovy sales in India double on month in July

Novo Nordisk Awiqli recommended for approval for diabetes by European regulatory authorities

Ruchika Sharma23 March 2024 2:12 PM IST

Awiqli is a once-weekly basal insulin analogue designed to cover the basal insulin requirements for a full week with a single subcutaneous injection.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok